Literature DB >> 7296709

Drug-carrier property of albumin microspheres in chemotherapy. V. Antitumor effect of microsphere-entrapped adriamycin on liver metastasis of AH 7974 cells in rats.

Y Morimoto, K Sugibayashi, Y Kato.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7296709     DOI: 10.1248/cpb.29.1433

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  6 in total

1.  S-S bonds are not required for the sonochemical formation of proteinaceous microspheres: the case of streptavidin.

Authors:  Sigalit Avivi; Aharon Gedanken
Journal:  Biochem J       Date:  2002-09-15       Impact factor: 3.857

2.  Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release.

Authors:  H S Yoo; J E Oh; K H Lee; T G Park
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

3.  Intra-arterial administration of heated albumin microspheres containing mitomycin C to rabbits with VX-2 tumor.

Authors:  S Fujimoto; F Endoh; M Miyazaki; R D Shreestha; K Okui; Y Morimoto
Journal:  Jpn J Surg       Date:  1984-05

4.  In vitro release profile of mitomycin C from albumin microspheres: extrapolation from macrospheres to microspheres.

Authors:  H Natsume; K Sugibayashi; Y Morimoto
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

5.  Continued in vitro and in vivo release of an antitumor drug from albumin microspheres.

Authors:  S Fujimoto; F Endoh; Y Kitsukawa; K Okui; Y Morimoto; K Sugibayashi; A Miyakawa; H Suzuki
Journal:  Experientia       Date:  1983-08-15

6.  Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report.

Authors:  Robert Cg Martin; Ken Robbins; Dana Tomalty; Ryan O'Hara; Petar Bosnjakovic; Radek Padr; Miloslav Rocek; Frantisek Slauf; Alexander Scupchenko; Cliff Tatum
Journal:  World J Surg Oncol       Date:  2009-11-03       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.